PUBLISHER: BCC Research | PRODUCT CODE: 1099254
PUBLISHER: BCC Research | PRODUCT CODE: 1099254
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
The equipment segment of the global patient monitoring devices market should reach $35.4 billion by 2022 and more than $54.6 billion by 2027, with a CAGR of 9% during the forecast period of 2022-2027.
The services segment of the global patient monitoring devices market should reach $4 billion by 2022 and more than $6 billion by 2027, with a CAGR of 8.5% during the forecast period of 2022-2027.
This report covers a range of products, some are disease specific and others are used for all types of patients and in general for health management. The patient monitoring device market referred to in this report is limited to the devices/products included in this report. Each product market covered in this report is unique and has a different set of market dynamics and competitive landscape. The product lifecycle of each product segment also varies.
The study will enable the audience to understand and gain insights on the current market and will forecast the changing market scenario. The data provided can help users understand which market segments among device connectivity, product type and end users are expected to grow at higher rates: factors driving growth, factors limiting the growth, key opportunity areas and so on.
Discussion and analysis cover the following market factors -
The report also covers a detailed competitive outlook, including market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, GE Healthcare, Philips Healthcare, Nihon Kohden, Omron Healthcare, Roche Diagnostics Ltd., Cardiocom, Covidien, CR Bard, Honeywell Med, Infinium Medical and InTechnology etc.